Please assess the completion status of the following clinical trial:

Trial Title: Oropharyngeal Administration of Colostrum to Extremely Low Gestational Age Newborns

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* premature infant with a gestational age less than 28 weeks born at Seoul National University Hospital and admit to the Seoul National University Children's Hospital NICU immediately after birth~* parents of the infant signed to the informed consent form with voluntary agreement~Exclusion Criteria:~* infants with major congenital anomalies or chromosomal syndromes~* infants of mothers not willing to provide colostrum in the first week of life~* infants of mothers with known infectious diseases that may be transmitted through the breast milk such as HIV, hepatitis C or active TB

- Gender: ALL
- Minimum Age: 48 Hours
- Maximum Age: 96 Hours
- Healthy Volunteers: t

Study Arms:
- Colostrum (Type: EXPERIMENTAL): oropharyngeal administration of own mother's colostrum
- Placebo (Type: PLACEBO_COMPARATOR): oropharyngeal administration of sterile water

Based on this trial design, predict the completion outcome and termination type (if applicable).